Robert Gensure
Pediatric Endocrinology · Manchester, NHNPI 1447208558
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $51,660 of the $56,559 with a category attached, or 91.3%. Biomarin Pharmaceutical Inc. accounts for 98.2% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $20,696, more than ten times the $352 reported in 2019.
Across 75 payments — averaging $754.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$56K
- Ultragenyx Pharmaceutical Inc.$367
- Tandem Diabetes Care, Inc.$135
- Insulet Corporation$125
- Kyowa Kirin, Inc.$114
- Dexcom, Inc.$73
- plus $204 from 9 others
Across 12 payments — averaging $11,629 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$93K
- OPKO Pharmaceuticals, LLC$31K
- Janssen Research & Development, LLC$15K
- Ascendis Pharma Endocrinology Inc$1K
What the payments were for
- Consulting fees$1,0152%
- Speaking & faculty fees$51,66091%
- Travel & lodging$2,0014%
- Food & beverage$1,4983%
- Education$3851%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 52 | $55,540 |
| Ultragenyx Pharmaceutical Inc. | 6 | $367 |
| Tandem Diabetes Care, Inc. | 3 | $135 |
| Insulet Corporation | 1 | $125 |
| Kyowa Kirin, Inc. | 1 | $114 |
| Dexcom, Inc. | 3 | $73 |
| Senseonics, Incorporated | 1 | $39 |
| Novo Nordisk | 1 | $32 |
| Endo Pharmaceuticals Inc. | 1 | $23 |
| Aegerion Pharmaceuticals, Inc. | 1 | $23 |
| Abbott | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| Tolmar Pharmaceuticals, Inc. | 1 | $17 |
| Pfizer | 1 | $15 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOXZOGO 1.2mg$24,583
- VOXZOGO$7,308
- CRYSVITA$269
- Omnipod$125
- t:slim X2 insulin pump$111
How this compares
Too few pediatric endocrinology providers in New Hampshireto place this figure against a meaningful peer group, so we don't.
Other pediatric endocrinology in Manchester
- Marissa AvolioManchester$984
- Luisa Fontes AguiarManchester$185
- Peter ClemonsBedford$60
- Nancy CharestBedford$60
- Michael MatosWolfeboro$42
- Frances Lim-LibertyLebanon$32
- Samuel CasellaLebanon$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.